When nanoparticles are used for drug delivery, they often end up in the liver or spleen instead of the intended target.

A team led by Jacob S. Brenner and Vladimir Muzykantov of the University of Pennsylvania now shows that nanocarrier delivery can be improved by the having the nanocarriers “hitchhike” on red blood cells (Nat. Commun. 2018, DOI: 10.1038/s41467-018-05079-7). The researchers withdrew red blood cells from mice and incubated them with nanoparticles, which adsorbed on the cell surface.

They then injected the cells back into the animals through arterial catheters. When injected this way, the nanocarriers accumulate in the first organ they encounter downstream from the injection site. The researchers think the narrow capillaries cause the nanoparticles to detach from the blood cells and transfer to the cells lining the capillaries.

Read more at cen.cs.org

Image Credit:  Nat. Commun

News This Week

Innovations in Nanocomposites: A Future Outlook

Nanocomposites are a class of nanomaterials, where one or more nanostructured materials (organic/inorganic) are incorporated in metal, polymer, or ceramic to obtain a new material with many unique properties. Nanocomposites are applied in various [...]

New sensor detects ever smaller nanoparticles

Conventional microscopes produce enlarged images of small structures or objects with the help of light. Nanoparticles, however, are so small that they hardly absorb or scatter light and, hence, remain invisible. Optical resonators increase [...]